Additional Use of Prostacyclin Analogs in Patients With Pulmonary Arterial Hypertension: A Meta-Analysis

Background: Combination therapy has become an attractive option in pulmonary arterial hypertension (PAH) treatment. The aim of this study was to investigate whether additional use of prostacyclin analogs could exert any additional benefits over background targeted therapies in PAH patients. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Pengwei, Deng, Jiaxin, Zhang, Quanying, Feng, Hongyan, Zhang, Yongheng, Lu, Yizhong, Han, Lizhu, Yang, Pengfei, Deng, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864222/
https://www.ncbi.nlm.nih.gov/pubmed/35222031
http://dx.doi.org/10.3389/fphar.2022.817119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864222/
https://www.ncbi.nlm.nih.gov/pubmed/35222031
http://dx.doi.org/10.3389/fphar.2022.817119

Ejemplares similares